FDA Upgrades Recall on 160,000 Bottles of Popular Thyroid Medication

Roughly 160,630 bottles of levothyroxine sodium tablets are under recall, the FDA said.

The Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters File Photo

The Food and Drug Administration (FDA) this week upgraded a recall of tens of thousands of bottles of a type of commonly prescribed thyroid medication.

Roughly 160,630 bottles of levothyroxine sodium tablets are under recall, the FDA said in multiple notices issued this week. The federal agency classified the levothyroxine sodium recall as Class II, which means that there is a moderate risk to public health.